Position in GSK
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$5,510,600
-$294,063 QoQ
Shares Held
105,124
-0.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.67%
of 13F equity value
Holder Rank
#157
of 1,032 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Stanley-Laman Group, Ltd. holds $19,104,441 across 5 Drug Manufacturers - General names. GSK ranks #2 (28.8% of the industry book) .
All Filings in GSK
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,510,600 | 105,124 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $5,804,663 | 105,176 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $5,106,829 | 104,136 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $4,189,239 | 97,063 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $3,757,209 | 97,844 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $4,785,629 | 123,532 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $3,626,146 | 107,219 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $5,333,204 | 130,460 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $4,125,929 | 107,167 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $411,080 | 9,589 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $355,368 | 9,589 | Shares | Sole | 2024-02-02 | |
| No filing history on record for this holder in this stock. | ||||||